ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » India News

Indian pharma companies better off than global peers: Moody's

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Indian pharma companies better off than global peers: Moody's
According to Moody's, Indian pharma market is highly fragmented with the largest player accounting for 8.8% of the $12 to $15 billion market. Representational Image. Image Source: Pixabay

Indian pharmaceutical companies possess stronger financial profiles than global counterparts due to economic growth forecast, solid product pipeline and geographical diversity further adding that merger and acquisitions (M&As) are likely going forward, said Moody's Investors Service. 

"When compared with their global counterparts, Indian pharmaceutical companies have stronger financial profiles with low leverage and high coverage metrics," Moody's vice president and senior analyst Kaustubh Chaubal, said in a press release on Friday. 
 
Moody's has recently released a presentation titled 'Indian Pharmaceutical Companies -- A Deep Dive' that compared the Indian pharmaceuticals firms to global peers and was co-authored by Kaustubh Chaubal and Diana Beketova.

As per the ratings agency's findings, the top Indian pharma companies although they are small in size when compared to global peers exhibit stronger financial profiles as most are promoter-owned and operate with conservative financial policies. 

ALSO READ: US DoJ's probe to have limited impact on Indian pharma cos: Fitch

The ownership by a founding family tends to align creditor and promoter-owner interests, thereby resulting in a more cautious risk appetite and low financial leverage in turn underpinning the companies' strong credit profiles, cited Moody's. 

"However, this ownership structure also raises the risks of related party transactions, potential slower responses to rapidly changing industry conditions and corporate underperformance," it added. 

According to Moody's, Indian pharma market is highly fragmented with the largest player accounting for 8.8% of the $12 to $15 billion (nearly Rs 79,833 crore to Rs 99,791.3 crore) market. 

The ratings agency has further projected merger and acquisitions (M&As) in Indian pharmaceutical sector due to rise in competition, attractive growth opportunities with consolidation in global generics, rise in regulatory risks, among others. 

"However, increasing competition, challenges in preserving their historical superior profitability and consolidation among large global generic companies will drive M&A activity for the Indian pharmaceutical sector," Moody's associate analyst Diana Beketova, said in a statement.   

On the consolidation of pharma companies globally and its impact on India, Moody's said that the Indian pharmaceutical sector is not immune to this trend. 

The ratings agency expects that Indian companies will explore inorganic growth primarily overseas as the large promoter ownership stakes may dissuade domestic M&A activities.

ALSO READ: Pharma stocks fall sharply as US drug pricing investigation nears completion

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Indian Pharma CompaniesEconomyM&Asmerger and acquisitionsconsolidation
Written By: Tejal Yerunkar
Updated: Fri, Nov 25, 2016
01:15 pm
Mumbai , ZeeBiz WebDesk
RELATED NEWS
US DoJ's probe to have limited impact on Indian pharma cos: Fitch US DoJ's probe to have limited impact on Indian pharma cos: Fitch
Brexit impact: Indian pharma seems immune, says Phillip Capital Brexit impact: Indian pharma seems immune, says Phillip Capital
Pharma stocks fall sharply as US drug pricing investigation nears completion Pharma stocks fall sharply as US drug pricing investigation nears completion

LATEST NEWS

Ramadan Mubarak 2023: Wishes, images, quotes, celebration visuals, messages to share on WhatsApp

Bharat Electronics share price: BEL stock in focus as PSU inks Rs 3,700-crore defence ministry contracts

Kitty O’Neil: Google doodle celebrates the spirit of the World-Fastest Women on her 77th birth anniversary

Traders' Diary: Buy, sell or hold strategy on SBI Card, Infosys, Wipro, RVNL, PB Fintech, 15 other stocks today

Chaitra Navratri 2023: Wishes, quotes, messages, greetings, pictures, quotes and colours to share on Whatsapp

Dividend, bonus stocks March 24: SAIL, BEL, Glenmark Life, other stocks to trade ex-date today

IPL 2023 new rules: Captains to announce Playing XI after toss, penalty for wicketkeeper’s unfair movement, and more

DA Hike Calculation: Dearness Allowance hiked to 42%; Bonanza in store for Central govt employees, pensioners - Check increase

BYJU's, Aakash deny merger talks with rival Unacademy

Good news for OPPO, Vivo, Xiaomi users! They can transfer data between these devices

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. Indiadotcom Digital Private Limited. All Rights Reserved.
LIVE TV